<SEC-DOCUMENT>0001949846-25-000005-index.html : 20250107
<SEC-HEADER>0001949846-25-000005.hdr.sgml : 20250107
<ACCEPTANCE-DATETIME>20250107161114
ACCESSION NUMBER:		0001949846-25-000005
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250107
DATE AS OF CHANGE:		20250107

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Janux Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001817713
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				822289112
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40475
		FILM NUMBER:		25514979

	BUSINESS ADDRESS:	
		STREET 1:		10955 VISTA SORRENTO PARKWAY
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 751-4493

	MAIL ADDRESS:	
		STREET 1:		10955 VISTA SORRENTO PARKWAY
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Campbell David Alan
		CENTRAL INDEX KEY:			0001864158
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O JANUX THERAPEUTICS, INC.
		STREET 2:		11099 N. TORREY PINES ROAD, SUITE 290
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>